Vaccine Therapy in Treating Patients With Recurrent Glioblastoma

NCT03360708 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

COMPLETED

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Giant Cell Glioblastoma
Recurrent Glioblastoma
Recurrent Gliosarcoma

Interventions

OTHER: Laboratory Biomarker Analysis
BIOLOGICAL: Malignant Glioma Tumor Lysate-Pulsed Autologous Dendritic Cell Vaccine

Sponsor

Mayo Clinic